Sword of Convallaria, a role-playing game published by XD Entertainment, a developer from Mainland China, recently launched in multiple global markets. This article delves into the advertising strategy behind its success, based on data from AppGrowing.
Advertising Overview
According to AppGrowing, Sword of Convallaria has launched a total of 1,206 ads across 14 regions and 7 advertising platforms. From July 1, 2024, to July 31, 2024, the game ran 934 ads, predominantly using in-feed and rewarded video ads, which together accounted for 86% of the total ad placements.
In-feed ads blend seamlessly into the user’s browsing experience, enhancing click-through and conversion rates. This choice likely stems from their high effectiveness on mobile devices, especially on social media platforms where dynamic content tends to attract more engagement.
Regarding ad creatives, Sword of Convallaria primarily employed horizontal and vertical videos, making up 98% of the ads. Video ads are highly effective in showcasing gameplay and features, thereby capturing player attention more effectively.
Peak Daily Ad Volume
Notably, on July 28, 2024, Sword of Convallaria reached a peak of 546 ads in a single day. This surge in advertising was a final push by XD to boost the game's visibility right before its launch. Concentrated ad placement in this period significantly increased the game’s exposure in a short timeframe.
Major Advertising Platforms
Sword of Convallaria predominantly used Meta Ads, with a total of 602 ads placed on this platform. Meta Ads' extensive user base and precise targeting capabilities make it a crucial channel for attracting potential players. By focusing a substantial portion of their ads on Meta Ads, XD effectively targeted their audience, improving conversion rates.
Conclusion
AppGrowing's analysis of Sword of Convallaria’s advertising strategy highlights its detailed and diversified approach to ad placement. This insight aims to provide valuable guidance for achieving greater success in future advertising campaigns.